Hong S Shen from 10001 43Rd Pl NE, Seattle, WA 98125, age 53, Phone: 2064913482

Name / Title

Company / Classification

Phones & Addresses

Hong Shen
Director, President, Secretary, Treasurer

Sh Southpoint Corp

Hong T. Shen
Principal

HONGYAN CORP
Nonclassifiable Establishments

105 Mamaroneck Ave, White Plains, NY 10601
24008 Oak Park Dr, Flushing, NY 11362

Lawyers & Attorneys

Hong Shen - Lawyer

view source

Specialties:

Business
Patent Application
Trademark Application
Patent Application

ISLN:

922528828

Admitted:

2010

University:

Concord Law School; Los Angeles CA; Foreign School

Medicine Doctors

Hong Shen

view source

Specialties:

Family Medicine

Work:

Shen Medical Associates
3100 4 St, Longview, TX 75605
9032474404 (phone), 9032474408 (fax)

Education:

Medical School
University of Texas Medical School at San Antonio
Graduated: 1998

Procedures:

Cardiac Stress Test
Arthrocentesis
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Skin Tags Removal
Vaccine Administration

Conditions:

Dementia
Osteoarthritis
Pneumonia
Abnormal Vaginal Bleeding
Acne

Languages:

Chinese
English
Spanish

Description:

Dr. Shen graduated from the University of Texas Medical School at San Antonio in 1998. He works in Longview, TX and specializes in Family Medicine. Dr. Shen is affiliated with Good Shepherd Medical Center and Longview Regional Medical Center.

Hong Shen

view source

Specialties:

Gastroenterology

Work:

The Oregon ClinicThe Oregon Clinic Gastroenterology - East At Gateway
1111 NE 99 Ave STE 301, Portland, OR 97220
5039632707 (phone), 5039632802 (fax)

Oregon ClinicOregon Clinic Gastroenterology East
10330 SE 32 Ave STE 210, Portland, OR 97222
5039632707 (phone), 5039632802 (fax)

Education:

Medical School
Univ of Western Australia, Fac of Med & Dent, Perth, Wa, Australia
Graduated: 1997

Procedures:

Colonoscopy
Sigmoidoscopy
Upper Gastrointestinal Endoscopy
Vaccine Administration

Conditions:

Abdominal Hernia
Acute Pancreatitis
Acute Pharyngitis
Anal Fissure
Anemia

Languages:

English

Description:

Dr. Shen graduated from the University of Western Australia in Perth. He later completed his internship and residency at Fremantle Hospital in Fremantle, Australia. Dr. Shen finished his internal medicine residency and gastroenterology fellowship at Indiana University Medical Center. He has been awarded the Travel Award for managing a Hepatitis B workshop and was the Acting Chief for the

Hong H. Shen

view source

Specialties:

Pain Management

Work:

Cleveland ClinicLutheran Hospital Pain Management Center
1730 W 25 St STE 4A, Cleveland, OH 44113
2163632391 (phone), 2163632107 (fax)

Education:

Medical School
Suzhou Med Coll, Suzhou City, Jiangsu, China
Graduated: 1984

Procedures:

Neurological Testing
Physical Therapy
Physical Therapy Evaluation

Languages:

English
Spanish

Description:

Dr. Shen graduated from the Suzhou Med Coll, Suzhou City, Jiangsu, China in 1984. She works in Cleveland, OH and specializes in Pain Management. Dr. Shen is affiliated with Cleveland Clinic and Lutheran Hospital.

Hong Shen

view source

Us Patents

Controlled Nucleic Acid Delivery Systems
view source
US Patent:

7030097, Apr 18, 2006
Filed:

Jul 14, 2000
Appl. No.:

09/616711
Inventors:

William Mark Saltzman - Ithaca NY, US
Dan Luo - Ithaca NY, US
Hong Shen - Ithaca NY, US
Nadya D. Belcheva - Ithaca NY, US
Assignee:

Cornell Research Foundation, Inc. - Ithaca NY
International Classification:

A01N 43/04
A61K 31/70
C12N 15/00
C12N 15/09
C12N 15/63
US Classification:

514 44, 435455, 435825, 4353201, 424450
Abstract:

One aspect of the present invention relates to a nucleic acid delivery system including a polymeric structure formed of a biocompatible polymer and a mixture comprising one or more nucleic acid molecules and a first co-dispersant, the mixture being contained within the polymeric structure, wherein the first co-dispersant is present in an amount effective to control diffusion of the one or more nucleic acid from the polymeric structure. Compositions including the nucleic acid delivery system and a pharmaceutically-acceptable carrier are disclosed. Methods of making the nucleic acid delivery system and their use in delivering nucleic acid into a patient and modifying gene expression in a target cell are also disclosed.

Method And System For Automatic Lung Segmentation
view source
US Patent:

7756316, Jul 13, 2010
Filed:

Dec 1, 2006
Appl. No.:

11/565711
Inventors:

Benjamin Odry - West New York NJ, US
Shuping Qing - Princeton NJ, US
Hong Shen - Plainsboro NJ, US
Assignee:

Siemens Medicals Solutions USA, Inc. - Malvern PA
International Classification:

G06K 9/00
US Classification:

382131, 382173, 382190
Abstract:

Disclosed is a systematic way of automatically segmenting lung regions. To increase the efficiency of a lung segmentation technique, a region-based technique, such as region growing, is performed by a computer on a middle slice of the CT volume. A contour-based technique is then used for a plurality of non-middle slices of the CT volume. This allows the implementation to be multithreaded and results in an improvement in the segmentation algorithm's efficiency.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment
view source
US Patent:

8168649, May 1, 2012
Filed:

Jun 26, 2006
Appl. No.:

11/922629
Inventors:

Subharekha Raghavan - Teaneck NJ, US
Steven L. Colletti - Princeton Junction NJ, US
Hong Shen - West Windsor NJ, US
James R. Tata - Westfield NJ, US
Ashley Rouse Lins - Edison NJ, US
Abigail Lee Smenton - Brooklyn NY, US
Weichun Chen - Livingston NJ, US
Darby Rye Schmidt - Clark NJ, US
George Scott Tria - La Jolla CA, US
Assignee:

Merk Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/44
A01N 43/40
A61K 31/19
A61K 31/165
US Classification:

514292, 514338, 514364, 514568, 514617
Abstract:

The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Methods For Producing Functional Antigen Presenting Dendritic Cells Using Biodegradable Microparticles For Delivery Of Antigenic Materials
view source
US Patent:

20050158856, Jul 21, 2005
Filed:

Jul 1, 2004
Appl. No.:

10/884519
Inventors:

Richard Edelson - Westport CT, US
Carole Berger - Bronx NY, US
Douglas Hanlon - Branford CT, US
Hong Shen - New Haven CT, US
International Classification:

C12N005/08
A61K009/16
A61K009/50
US Classification:

435372000, 424490000
Abstract:

Methods are provided for producing functional antigen presenting dendritic cells. The dendritic cells are produced by treating an extracorporeal quantity of a subject's blood to induce differentiation of blood monocytes into dendritic cells. The dendritic cells may be exposed to cellular material encapsulated within a biodegradable polymer material to produce the antigen presenting dendritic cells.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment
view source
US Patent:

20060293364, Dec 28, 2006
Filed:

Jun 26, 2006
Appl. No.:

11/474646
Inventors:

Subharekha Raghavan - Teaneck NJ, US
Steven Colletti - Princeton Junction NJ, US
Hong Shen - West Windsor NJ, US
James Tata - Westfield NJ, US
Ashley Lins - Edison NJ, US
Abigail Smenton - Brooklyn NY, US
Weichun Chen - Livingston NJ, US
Darby Schmidt - Clark NJ, US
George Tria - La Jolla CA, US
International Classification:

A61K 31/4439
A61K 31/43
A61K 31/427
A61K 31/4245
A61K 31/416
A61K 31/4192
A61K 31/35
A61K 31/195
US Classification:

514341000, 514365000, 514366000, 514379000, 514469000, 514563000, 548151000, 548202000, 548253000, 548240000, 562450000, 514406000, 548375100, 546269100, 514459000, 514359000
Abstract:

The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment
view source
US Patent:

20120178750, Jul 12, 2012
Filed:

Mar 19, 2012
Appl. No.:

13/423618
Inventors:

Subharekha Raghavan - Teaneck NJ, US
Steven L. Colletti - Princeton Junction NJ, US
Hong Shen - West Windsor NJ, US
James R. Tata - West Windsor NJ, US
Ashley Rouse Lins - Midlothian VA, US
Abigail Lee Smenton - Edison NJ, US
Weichun Chen - Livingston NJ, US
Darby Rye Schmidt - Clark NJ, US
George Scott Tria - Princeton NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/4439
A61K 31/423
A61K 31/429
A61K 31/41
A61K 31/426
A61K 31/427
A61K 31/403
A61K 31/4375
A61K 31/437
A61K 31/538
A61K 31/4196
A61P 9/10
A61P 3/06
A61P 3/10
A61P 3/00
A61K 31/196
US Classification:

5142305, 514563, 514379, 514366, 514381, 514365, 514340, 514341, 514411, 514292, 514294, 514383
Abstract:

The present invention encompasses compounds of Formula I:as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Novel Spiropiperidine Prolylcarboxypeptidase Inhibitors
view source
US Patent:

20130023515, Jan 24, 2013
Filed:

Apr 21, 2011
Appl. No.:

13/638976
Inventors:

Jinlong Jiang - Scotch Plains NJ, US
Hong Shen - West Windsor NJ, US
Zhi-Cai Shi - Monmouth Junction NJ, US
International Classification:

C07D 491/107
C07D 491/20
A61K 31/438
A61K 31/5377
A61K 31/4545
A61K 31/496
A61K 31/506
A61K 31/497
A61K 31/501
A61K 31/519
A61K 31/4985
A61K 31/44
A61P 3/04
A61P 3/10
A61P 3/00
A61K 31/444
US Classification:

51421002, 546 17, 514278, 544 70, 5142335, 544230, 51425311, 514256, 51425505, 51425203, 5142591, 514249
Abstract:

Compounds of structural formula (I) are inhibitors of prolylcarboxypeptidase (PrCP). The compounds of the present invention are useful for the prevention and treatment of conditions related to enzymatic activity of PrCP such as abnormal metabolism, including obesity; diabetes; metabolic syndrome; obesity related disorders; and diabetes related disorders.

Environmentally-Responsive Nanocomposites And Methods Of Their Use
view source
US Patent:

20130224261, Aug 29, 2013
Filed:

Feb 19, 2013
Appl. No.:

13/770943
Inventors:

University of Washington Through Its Center For Commercialization - Seattle WA, US
Hong Shen - Seattle WA, US
Assignee:

University of Washington Through Its Center For Commercialization - Seattle WA
International Classification:

A61K 48/00
US Classification:

424400, 514 54, 514 11, 514 44 R, 514769, 435375
Abstract:

Environmentally-responsive composites useful for intracellular delivery of therapeutic agents.